This presentation was done by Dr. Julius P. Kessy,MD. An intern Doctor at Dodoma Regional Referral Hospital (DRRH) during pediatrics unit clinical meeting and supervised by Dr. Christina K. Galabawa,MD,Mmed2, Pediatrics and Child Health, University of Dodoma (UDOM) in November, 2017.
This presentation was done by Dr. Julius P. Kessy,MD. An intern Doctor at Dodoma Regional Referral Hospital (DRRH) during pediatrics unit clinical meeting and supervised by Dr. Christina K. Galabawa,MD,Mmed2, Pediatrics and Child Health, University of Dodoma (UDOM) in November, 2017.
This presentation focuses on Acute Bacterial Meningitis.
Viral and fungal cause is mentioned but focus is on bacterial meningitis in Pediatrics Patient.
Feel free to correct if there is any error.
Refer to other reference books for clarity.
This presentation focuses on Acute Bacterial Meningitis.
Viral and fungal cause is mentioned but focus is on bacterial meningitis in Pediatrics Patient.
Feel free to correct if there is any error.
Refer to other reference books for clarity.
Pediatric Type 2 Diabetes Mellitus. BY DR SAYED ISMAILSayed Ahmed
diabetes mellitus type 2 in children
pathophysiology of type 2 DM
manifestations of DM
Complications , investigation and management of type2 DM in children
Cough in children.pptx by dr sayed ismailSayed Ahmed
causes of cough in children
acute and chronic cough
approach to cough in children
common causes of cough
treatment of cough
investigation of cough
neonatal cough
differntial diagnosis of cough
impact of cough
complications of cough
prolonged cough
persistent cough
constipation in children , pediatric constipation , management of constipation in children , understanding constipation , causes of constipation in children , functional constipation in children , treatment of constipation ,approach to constipation in children ,constipation in infants
syncope in children , vasovagal syncope , fainting in children , causes of syncope in children , how to manage syncope in children , cardiac syncope , differnetial diagnosis of syncope , approach to syncope
how to examine sick baby , approach to child medical examination , diagnosis of sick child , evaluation of sick baby , medical examination of children , child medical history and examination , care of children
obesity in children , causes of obesity, approach to children obesity, complication of obesity, obesity definition, how to manage obesity, guidelines in pediatric obesity
simlpe approach to anemia in children , how to diagnose anemia in kids ,types of anemias ,causes of anemia , iron deficeincy anemia, hemolytic anemias , laboratory tests in anemia ,
UPPER RESIRATORY TRACT INFECTIONS IN CHILDREN , ACUE PHARYGITIS , COMMON COLD , ACUTE SINUSITIS , ACUTE OTITIS MEDIA , APPROACH TO PATIENT WITH URTI , MANAGEMENT OF URTI IN CHILDREN
pediatric assessment in emergency rooms , how to pass the PALS exam , part 1 search for the other 3 parts, for any comment send to sayedahmed 1900@ g mail .com
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
2. Definitions and Terms
• Acute Gastroenteritis (AGE):
Gastroenteritis is defined as the inflammation of the mucus membranes of
the Gastrointestinal tract and is characterized by diarrhea , fever and
vomiting.
• Diarrhea: the frequent passage of liquid stools (3 or more loose,
watery stool per day)
• Dysentery: blood or mucus in stools
6. Pathophysiology
The 2 primary mechanisms
(1) Damage to the villous brush border of the intestine malabsorption of intestinal contents an
osmotic diarrhea
(2) Release of toxins that bind to specific enterocyte receptorsrelease of chloride ions into the
intestinal lumensecretory diarrhea
7.
8. Causes of acute gastroenteritis in children
Viruses (~70%)
Rotaviruses
Norwalk (noroviruses)
Adenoviruses
Caliciviruses
Astroviruses
Enteroviruses
Bacteria (~15%)
Enterotoxigenic Ecoli
Campylobacter jejuni
Salmonella spp
Enteropathogenic E. coli
Shigella spp
Yersinia enterocolitica
Cholera
C difficile
Protozoa
Giardia lamblia
Entamoeba histolytica
Cryptosporidium
Helminths
Strongyloides stercoralis
9. Virus Character incubation period duration
Rota virus commonest
dehydrating diarrhea
1-3 d 5-7 d
Norwalk virus
(noroviruses)
outbreaks of GE in both
children and adults
1-3 d 1-2 d
Adeno virus 2ND common after rota 8-10 d 5-12 d
Viral infections
10. Bacterial infections
• E. coli infection, typhoid and
shigellosis are more in developing
communities.
• Clostridium difficile :
pseudomembranous colitis, observed
in patients who develop severe
diarrhea during or following a course
of antibiotics.
• In patients with sickle cell disease,
Salmonella species are the most
frequent cause of gastroenteritis
13. Diarrhea
• Watery stools are more consistent with
viral gastroenteritis
• Stools with blood or mucous are
indicative of a bacterial pathogen.
• a long duration of diarrhea (>14 days)
1. parasitic
2. noninfectious cause of diarrhea.
15. Lab Studies
• Are not required if the etiology is apparent and some dehydration is present.
With severe dehydration, the following are suggested
Serum electrolytes Because hyponatremia and hypernatremia
require specific treatment
Bicarbonate concentration Useful in ruling out dehydration
Poor tissue perfusion in dehydration results in
production of lactic acid
Loss of bicarbonate in diarrheal stools.
Glucose May be dangerously low because of poor intake
Blood urea and creatinine Elevated in renal hypoperfusion.
Urine specific gravity
Stool examination / culture
Steiner, DeWalt & Byerley, 2004.
16. Stool examination
Presence of pus,
RBC, or gross blood.
Invasive bacterial pathogen
No pus or RBC No invasive GE
Stool cultures
or rectal swab
Bloody diarrhea
Immunocompromised
Toxemia
Virus detection Rapid antigen detection in
stool
Evidence of systemic infection-complete workup:
CBC and blood cultures. If indicated, urine cultures, chest radiography, and/or LP
18. • Irritability
• No tears when crying
• Sunken eye
• Thirst
• Lethargy
• Dry mouth and skin
Symptoms of dehydration
19. Skin turgor is assessed by pinching the skin of the abdomen or thigh
between the thumb and the bent forefinger in a longitudinal manner.
The sign is unreliable in obese or severely malnourished children.
21. Clinical Findings of Dehydration:
Symptom Minimal or no
Dehydration (<3%)
Mild to Moderate
(3%-9%)
Severe
(>10%)
Mental Status Alert Normal, restless,
irritable
Lethargic,
unconscious
Thirst Normal PO or
refuses
Thirsty Drinks poorly or
unable
Heart Rate Normal Normal to increased Tachycardia
Quality of pulses Normal Normal to
decreased
Weak or impalpable
Breathing Normal Normal to fast Deep
Eyes Normal Slightly sunken Deeply sunken
Tears Present Decreased Absent
Oral mucosa Moist Dry Parched
Skin fold Instant recoil Recoil in < 2 sec Recoil > 2sec
Capillary refill Normal Prolonged Prolonged; minimal
Extremities Warm Cool Cool, mottled,
cyanotic
Urine output Normal to decrease Decreased Minimal
22. Seizures in a patient with diarrhea
Causes :
1. Shigella species
2. Enterohemorrhagic Escherichia coli
3. Electrolyte imbalance , ↕Na
23. Management
Basic guidelines for the management of dehydration
• ORS should be use for rehydration
• Oral rehydration should be performed within 3-4 hr
• Rapid realimentation, an age-appropriate unrestricted diet is recommended
as soon as dehydration is corrected. Gut rest is not indicated
• In breastfeed infants, nursing should continue
• Diluted formula or special formulas are not indicated
• Additional ORS can be administer for ongoing losses
• No unnecessary labs or medications (i.e. antidiarrheals)
Ozuah PO, Avener JR, et al. Pediatrics 2002;109:259-261
24. Minimal or no dehydration
• If the child is breastfed, give breastfeeding more frequently than
usual and for longer at each feed.
• If not breastfed, then oral fluids (including clean water, soup, rice
water, yogurt drink
• For ongoing fluid losses give 10 mL/kg ORS for each loose stool
and 2 mL/kg for each episode of emesis
25. In the human body, the plasma osmolality is about 285 mOsm/l
Composition of Oral Rehydration Solutions
Solution Carbs
(gm/L)
Sodium
(mmol/L
Potassium
(mmol/L)
Chloride
(mmol/L
Base
(mmol/L)
Osmolarity
(mOsm/L)
WHO-ORS
(2002)
13.5 75 30 65 30 245
WHO-ORS
(1975)
20 90 20 80 30 311
Pedialyte 25 45 20 35 30 250
Enfalyte 30 50 25 45 34 200
Rehydralyte 25 75 20 65 30 305
CeraLyte 40 50-90 20 N/A 30 220
Gatorade 14 110 30 290-303
Apple Juice 120 0.4 44 45 N/A 730
Coca-Cola 112 1.6 N/A N/A 13.4 650
26. Mild-to-moderate dehydration
• Give 50-100 mL/kg of ORS over a 2- to 4-hour period.
• After the initial rehydration phase, mange as before
• ORS should be given slowly at rate of 5 mL every 1-2 mim
• For patients who do not tolerate ORS by mouth, nasogastric
(NG) feeding
27. Hypernatremic dehydration
• An exception to this, is the management of hypernatrernic
dehydration (> 150 mmol/L of sodium). Hypernatremic
dehydration should be corrected with the same volumes of
ORS described above, but over 12 hours instead of 4
hours.
• This reduces the risk of seizures associated with rapid
correction of hypernatremia in mild-to-moderate
dehydration.
Lifschitz , Current Opinion in Pediatrics 1997;9:498-501.
28. The falx appears to be prominent. This white enhancement represents hemorrhage in the
interhemispheric space. It is most prominent posteriorly. This represents a posterior
interhemispheric subdural hematoma. There is evidence of cerebral edema and a slight midline
shift
Rapid correction of
Hypernatremic
dehydration
Brain edema
30. Severe dehydration
• Is a medical emergency
• IV bolus of 20-30 mL/kg (LR) or
(NS) solution over 60 minutes.
• Repeat till pulse, perfusion, and/or
mental status improve
• After this, the patient should be given
an infusion of 70 mL/kg LR or NS
over 5 hours (children < 12 months)
or 2.5 hours (older children).
• Once resuscitation is complete ,
rehydration should continue with ORS
as described above
32. When to admit children with AGE
1. Inability to tolerate oral rehydration therapy
2. Severely dehydrated or in shock
3. At high risk of dehydration
• < 6 months old
• High frequency of watery stools or vomits
• Minimal oral intake
• Worsening symptoms
• If the parent or carer is unable to manage the child at home.
4. At high risk of complications
• Children with significant underlying disease (eg, diabetes, renal
failure, SCD..)
• High fever
• Poor nutrition
• Hypernatremic
• Hyponatremic states
Malnutrition
33. Antimicrobials
Generally not indicated
• C difficile- stop antibiotic & start metronidazole
• Cholera-tetracycline and doxycycline
• Giardia-metronidazole
• Cryptosporidium-metronidazole or Nitazoxanide
American Academy of Pediatrics, Pediatrics 1996; 97: 424-435
34. Antidiarrheals are not recommended
– Loperamide has been linked to cases of severe abdominal
distention and even death
• Ondasetron
– a serotonin antagonist antiemetic
– Effective in decreasing vomiting and facilitates ORT
– Proven efficacious and safe in children > 6 months
– Shown to shorten the ED stay
Freedman , et al. The New England Journal of Medicine 2006;354:1698-705
35. Probiotics
• Probiotics are live microbial feeding supplements
• Possible mechanisms of action include synthesis of antimicrobial
substances, competition with pathogens for nutrients, modification of toxins,
and stimulation of nonspecific immune responses to pathogens.
• Two large systematic reviews have found probiotics (especially Lactobacillus
GG) to be effective in reducing the duration of diarrhea
• A recent meta-analysis found probiotics may be especially effective for the
prevention of C difficile –associated diarrhea in patients receiving
antibiotics.
Allen et al, Cochrane Database Syst Rev. 2004;
36. zinc
• zinc supplementation may be effective in
reducing the duration of diarrhea in
children older than 6 months in areas
where zinc deficiency is prevalent.
• WHO recommends zinc supplementation
(10-20 mg/day for 10-14 days) for all
children younger than 5 years with acute
gastroenteritis
• little data support this recommendation
for children in developed countries
Lazzerini and Ronfani L. Cochrane Database Syst Rev. 2012
38. References
• Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG. Global, regional, and national causes of child mortality in 2008: a
systematic analysis. Lancet. 2010 Jun 5. 375(9730):1969-87. [Medline].
• King CK, Glass R, Bresee JS, Duggan C,. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional
therapy. MMWR Recomm Rep. 2003 Nov 21. 52(RR-16):1-16. [Medline].
• Dennehy PH. Acute diarrheal disease in children: epidemiology, prevention, and treatment. Infect Dis Clin North Am. 2005 Sep.
19(3):585-602. [Medline].
• Hullegie S, Bruijning-Verhagen P, Uiterwaal CS, et al. First-year Daycare and Incidence of Acute Gastroenteritis. Pediatrics. 2016.
137(5):e20153356.
• Fischer Walker CL, Perin J, Aryee MJ, Boschi-Pinto C, Black RE. Diarrhea incidence in low- and middle-income countries in 1990 and
2010: a systematic review. BMC Public Health. 2012. 12:220. [Medline].
• Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg
Infect Dis. 2003 May. 9(5):565-72. [Medline].
• Boschi-Pinto C, Velebit L, Shibuya K. Estimating child mortality due to diarrhoea in developing countries. Bull World Health Organ. 2008
Sep. 86(9):710-7. [Medline].
• Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and
2000. Bull World Health Organ. 2003. 81(3):197-204. [Medline].
• Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in
children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-
analysis. Lancet Infect Dis. 2012 Feb. 12(2):136-41. [Medline].
• Payne DC, Vinje J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA. Norovirus and medically attended gastroenteritis in U.S.
children. N Engl J Med. 2013 Mar 21. 368(12):1121-30. [Medline].
• World Health Organization. Treatment of diarrhoea: a manual for physicians and other senior health workers, 4th ed. 2005. Available
at http://209.61.208.233/LinkFiles/CAH_Publications_manual_physicians.pdf. Accessed: March 26, 2013. MacReady N. Juice, Other
Drinks Can Manage Mild Gastroenteritis in Children. Medscape Medical News. Available
at http://www.medscape.com/viewarticle/862764. May 03, 2016; Accessed: May 27, 2016Panigrahi P, Parida S, Nanda NC, Satpathy R,
Pradhan L, Chandel DS, et al. A randomized synbiotic trial to prevent sepsis among infants in rural India. Nature. 2017 Aug 24. 548
(7668):407-412. [Medline].
Editor's Notes
Because most cases of acute gastroenteritis in developed and developing countries are due to viruses, antibiotics are generally not indicated. Even in cases (eg, dysentery) where a bacterial pathogen is suspected, antibiotics may prolong the carrier state (Salmonella) or may increase the risk of hemolytic uremic syndrome (enterohemorrhagic E coli).30
Antidiarrheals (e.g. loperamide, opiates, bismuth subsalicylate) are not recommended for
use in AGE. Opiates are contraindicated, and the others have limited scientific evidence
to outweigh risks)
§ Antiemetics currently antiemetics
are not recommended in the treatment of AGE.
Though some clinical studies have demonstrated that ondansetron can decrease vomiting
and hospitalization.
n February 2006, the US Food and Drug Administration (FDA) approved the RotaTeq vaccine for prevention of rotavirus gastroenteritis. The vaccine has been endorsed by the American Academy of Pediatrics (AAP).In April 2008, the FDA approved Rotarix, another oral vaccine, for prevention of rotavirus gastroenteritis. The current recommendation is to administer 2 separate doses of Rotarix to patients aged 6-24 weeks. Rotarix was efficacious in a large study, which reported that Rotarix protected patients with severe rotavirus gastroenteritis and decreased the rate of severe diarrhea or gastroenteritis of any cause.26 Recent large trials in both Latin America and Africa have also found Rotarix to be effective in decreasing diarrhea morbidity and mortality in children.27,28,29
Clinical trials reported that the vaccines prevented 74-78% of all rotavirus gastroenteritis cases